CIRC News

China Tongspoke (1763.HK): High performance of leading nuclear medicine barriers is expected to determine continued growth

國元國際Sep 30, 2021 00:00

China Tongspoke (1763.HK) 2021 Semi-Annual Report Review: Nuclear Drug Business Has Resumed Strong and Comprehensive Competitiveness Continues to Grow

光大證券Sep 1, 2021 00:00

China Tongspoke (1763.HK): The announcement suggests issuing A shares and listing will help improve the liquidity of Hong Kong stocks

中金公司Feb 1, 2021 00:00

China Tongspoke (01763.HK): Leading nuclear medicine companies have high barriers and rich product lines

國元國際Sep 10, 2020 00:00

China Tongfu (01763.HK): the performance is in line with expectations and the introduction of radium chloride [223RA] injection

中金公司Sep 1, 2020 00:00

China 01763.HK: a new configuration plan for large-scale medical equipment is good for related products

中金公司Aug 11, 2020 00:00

China Tongspoke (01763.HK): The F18-FDG market is expected to expand equity incentives and improve efficiency

中金公司Jul 15, 2020 00:00

China 01763.HK: revenue remains strong but net profit is lower than expected

中金公司Apr 1, 2020 00:00

China 01763.HK: the construction of nuclear pharmacy is smooth

中金公司Feb 28, 2020 00:00

China 01763.HK: the introduction of equity incentive scheme is expected to ensure the company's long-term development.

中金公司Dec 16, 2019 00:00

China Tongxu (01763.HK): Signed an agreement with ITM to introduce large-scale production of two products

中金公司Nov 19, 2019 00:00

中国同辐(01763.HK)：业绩超预期 主营业务发展迅速

中金公司Sep 4, 2019 00:00

Tongzhou, China (01763.HK): Radiopharmaceutical market is expected to expand further

中金公司Apr 23, 2019 00:00

中国同辐(01763.HK)2018年业绩小幅超预期；主要产品收入增长强劲

中金公司Apr 1, 2019 00:00

中国同辐(01763.HK)：两项动作有助于强化市场定位和延伸产业链

中金公司Feb 12, 2019 00:00

China Tongspoke (01763.HK) research minutes: urea breath test kit sales continue to grow rapidly, and the F18-FDG market is expected to expand

中金公司Nov 14, 2018 00:00